Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 768 | 590 | 486 | 585 | 1,215 |
| Operating Income | -768 | -590 | -486 | -585 | -1,215 |
| Other Income | 3 | -9 | -6 | -34 | 26 |
| Pre-tax Income | -765 | -599 | -492 | -619 | -1,189 |
| Net Income Continuous | -765 | -599 | -492 | -619 | -1,189 |
| Net Income | $-765 | $-599 | $-492 | $-619 | $-1,189 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.06 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.06 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.06 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.06 |
| EBITDA(a) | $-767 | $-590 | $-486 | $-584 | $-1,213 |